title: Anti-proliferative and angio-suppressive effect of Stoechospermum marginatum (C. Agardh) Kutzing extract using various experimental models.
abstract: OBJECTIVE
  Abundant consumption of seaweeds in the diet is epidemiologically linked to the reduction in risk of developing cancer. In larger cases, however, identification of particular seaweeds that are accountable for these effects is still lacking, hindering the recognition of competent dietary-based chemo preventive approaches. The aim of this research was to establish the antiproliferative potency and angiosuppressive mode of action of Stoechospermum marginatum seaweed methanolic extract using various experimental models.
  
  
  METHODS
  Among the 15 seaweeds screened for antiproliferative activity against Ehrlich ascites tumor (EAT) cell line, Stoechospermum marginatum extract (SME) was found to be the most promising. Therefore, it was further investigated for its anti-proliferative activity in-vitro against choriocarcinoma (BeWo) and non-transformed Human embryonic kidney (HEK 293) cells, and for its anti-migratory/tube formation activity against HUVEC cells in-vitro. Subsequently, the angiosuppressive activity of S. marginatum was established by inhibition of angiogenesis in in-vivo (peritoneal angiogenesis and chorioallantoic membrane assay) and ex-vivo (rat cornea assay) models.
  
  
  RESULTS
  Most brown seaweed extracts inhibited the proliferation of EAT cells, while green and red seaweed extracts were much less effective. According to the results, SME selectively inhibited proliferation of BeWo cells in-vitro in a dose-dependent manner, but had a lesser effect on HEK 293 cells. SME also suppressed the migration and tube formation of HUVEC cells in-vitro. In addition, SME was able to suppress VEGF-induced angiogenesis in the chorio allantoic membrane, rat cornea, and tumor induced angiogenesis in the peritoneum of EAT bearing mice. A decrease in the microvessel density count and CD31 antigen staining of treated mice peritoneum provided further evidence of its angiosuppressive activity.
  
  
  CONCLUSIONS
  Altogether, the data underline that VEGF mediated angiogenesis is the target for the angiosuppressive action of SME and could potentially be useful in cancer prevention or treatment involving stimulated angiogenesis.
authors.affiliation: Biological Oceanography Division, National Institute of Oceanography, Dona Paula, Panaji, Goa 403004, India.
authors.forename: Rashmi
authors.initials: R
authors.lastname: Vinayak
authors.affiliation: Department of Studies in Biotechnology, University of Mysore, Manasagangothri, Mysore 570006, India.
authors.forename: Shilpa
authors.initials: S
authors.lastname: Puttananjaiah
authors.affiliation: Biological Oceanography Division, National Institute of Oceanography, Dona Paula, Panaji, Goa 403004, India.
authors.forename: Anil
authors.initials: A
authors.lastname: Chatterji
authors.affiliation: Department of Studies in Biotechnology, University of Mysore, Manasagangothri, Mysore 570006, India.
authors.forename: Bharati
authors.initials: B
authors.lastname: Salimath
keywords: Angiogenesis; VEGF; anti-proliferation; antitumor; seaweeds
references.citation: Mol Cell Biochem. 2003 Jan;243(1-2):107-12
references.pmid: 12619895
references.citation: Anat Rec. 2001 Dec 1;264(4):317-24
references.pmid: 11745087
references.citation: Nat Med. 2000 Apr;6(4):389-95
references.pmid: 10742145
references.citation: Cell. 1996 Aug 9;86(3):353-64
references.pmid: 8756718
references.citation: J Nutr. 2002 May;132(5):946-51
references.pmid: 11983819
references.citation: J Biol Chem. 1992 Jun 5;267(16):10931-4
references.pmid: 1375931
references.citation: Oncogene. 2002 May 30;21(24):3889-97
references.pmid: 12032827
references.citation: Clin Cancer Res. 2001 Jan;7(1):93-7
references.pmid: 11205924
references.citation: Cancer Res. 1996 Sep 1;56(17):4032-9
references.pmid: 8752175
references.citation: Biochimie. 2006 Mar-Apr;88(3-4):297-307
references.pmid: 16216405
references.citation: Int Rev Exp Pathol. 1976;16:207-48
references.pmid: 783062
references.citation: J Oncol. 2010;2010:132641
references.pmid: 20445741
references.citation: Cytotechnology. 2005 Jan;47(1-3):117-26
references.pmid: 19003051
references.citation: Nature. 1993 Apr 29;362(6423):841-4
references.pmid: 7683111
references.citation: Microvasc Res. 2013 Jul;88:12-8
references.pmid: 23507505
references.citation: Evid Based Complement Alternat Med. 2011;2011:673083
references.pmid: 21860651
references.citation: Bioresour Technol. 2008 May;99(8):2717-23
references.pmid: 17706415
references.citation: Int J Mol Med. 2005 Apr;15(4):695-9
references.pmid: 15754034
references.citation: Pharmacol Res. 2008 Apr;57(4):259-65
references.pmid: 18387817
references.citation: Curr Opin Pharmacol. 2002 Aug;2(4):403-14
references.pmid: 12127873
references.citation: J Clin Invest. 2000 Apr;105(8):1045-7
references.pmid: 10772648
references.citation: J Natl Cancer Inst. 1990 Jan 3;82(1):4-6
references.pmid: 1688381
references.citation: J Clin Oncol. 2001 Feb 15;19(4):1195-206
references.pmid: 11181686
references.citation: J Clin Invest. 2000 Apr;105(8):R15-24
references.pmid: 10772661
references.citation: J Clin Invest. 1999 Dec;104(11):1497-501
references.pmid: 10587512
references.citation: Exp Eye Res. 2005 Mar;80(3):435-42
references.pmid: 15721625
references.citation: Int Immunopharmacol. 2006 Mar;6(3):494-8
references.pmid: 16428085
references.citation: Microvasc Res. 2008 Jan;75(1):34-44
references.pmid: 17585952
references.citation: Nat Rev Cancer. 2002 Oct;2(10):727-39
references.pmid: 12360276
references.citation: Nat Protoc. 2007;2(2):329-33
references.pmid: 17406593
references.citation: Circ Res. 2000 Nov 10;87(10):840-4
references.pmid: 11073878
references.citation: Nat Med. 1995 Jan;1(1):27-31
references.pmid: 7584949
references.citation: J Natl Cancer Inst. 2001 Nov 21;93(22):1685
references.pmid: 11717328
references.citation: Clin Sci (Lond). 2001 Nov;101(5):499-506
references.pmid: 11672455
references.citation: BMC Complement Altern Med. 2008 Jul 10;8:38
references.pmid: 18613983
references.citation: Am J Pathol. 1998 Oct;153(4):1249-56
references.pmid: 9777956
references.citation: J Oncol. 2010;2010:214186
references.pmid: 21461373
references.citation: World J Gastroenterol. 2007 Dec 14;13(46):6269-73
references.pmid: 18069772
references.citation: Postgrad Med J. 2005 Apr;81(954):236-42
references.pmid: 15811887
references.citation: Cancer Res. 2000 Apr 1;60(7):1878-86
references.pmid: 10766175
references.citation: J Sci Food Agric. 2011 Oct;91(13):2471-6
references.pmid: 21674507